Latest Isologic News
News, Insight, Education – Welcome to the Isologic Blog
CPDC, New acquisition
Dear customers, We are pleased to announce that Isologic has just completed the acquisition of the FDG Canadian distribution business from Centre for Probe Development and Commercialization (CPDC). As a result, all FDG customers serviced by CPDC are, effective December 1st, serviced by Isologic out of our Toronto (Sunnybrook) facility. [...]
Facility Disclosure
Facility Disclosure
NEW PRODUCT AVAILABLE
Antimony Sulfide Colloid Tc99m injection January 9th, 2020 Dear Valued Customer, It is with great pleasure that we would like to inform you that Isologic has a new product within its portfolio. We are introducing Antimony Sulfide Colloid Tc99m injection. This product is indicated for use as [...]
Gallium-68 generator, Galli Eo®
IRE Elit and Isologic announce the approval of the Gallium-68 generator, Galli Eo®, as a drug in Canada December 5th, 2019 - Fleurus, Belgium & Montreal, Canada: IRE ELIT, Belgian radiopharmaceutical company, has just received the Notice of Compliance (NOC) from Health Canada for its drug [...]
I-131 Update June 27, 2019
I-131 capsule and solution production update June 27th, 2019 Dear Valued Customer, We have been informed by our supplier that the last shipment of Sodium Iodide I-131 products (Therapeutics and Diagnostics) to the Canadian market will be June 26th and no production will occur until July 11th. Our [...]
General Nuclear Medicine News
News and Education provided by World Leading Experts
CPDC, New acquisition
Dear customers, We are pleased to announce that Isologic has just completed the acquisition of the FDG Canadian distribution business from Centre for Probe Development and Commercialization (CPDC). As a result, all FDG customers serviced by CPDC are, effective December 1st, serviced by Isologic out of our Toronto (Sunnybrook) facility. [...]
First diagnostic radiotracer for early diagnosis of Alzheimer’s disease approved in Canada
PIRAMAL IMAGING SA AND ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ANNOUNCE COMMERCIAL APPROVAL OF NEURACEQ™ BY HEALTH CANADA MONTREAL, Feb. 28, 2017 /CNW Telbec Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce that Health Canada has issued a Notice of Compliance (NOC) to ISOLOGIC [...]
IRE-ELiT S.A. & Isologic Sign Exclusive Agreement
IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic signed an exclusive agreement for the distribution of Galli Eo™ 68Ge/ 68Ga generator in Canada FLEURUS, Belgium ; Montreal, Canada ; the 31st January. IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic Innovative Radiopharmaceuticals, the Canadian [...]
ISOLOGIC Acquires Lantheus Canadian Imaging Centres
ISOLOGIC Acquires Lantheus Canadian Imaging Centres ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ACQUIRES LANTHEUS MEDICAL IMAGING CANADIAN RADIOPHARMACEUTICAL CENTRES ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef manufacturing and distribution [...]
Piramal Announces Strategic Partnership with ISOLOGIC
PIRAMAL IMAGING ANNOUNCES STRATEGIC PARTNERSHIP WITH ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS FOR EXCLUSIVE COMMERCIALIZATION OF NEURACEQ IN CANADA BOSTON, June 4, 2015 Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce the companies have entered into a strategic partnership and licensing agreement [...]
Canadian Radiopharmacy Acquisitions
PHARMALOGIC P.E.T. SERVICES OF MONTREAL COMPANY AND CARDINAL HEALTH CANADIAN RADIOPHARMACY ACQUISITIONS March 24th, 2014 IsoLogic is proud to announce that following the acquisitions of Pharmalogic P.E.T. Services of Montreal and Cardinal Health’s Ontario based radiopharmacies, it will operate the combined businesses as [...]